Vivimed Labs Limited — Board Meeting, 11-01-2025: Outcome of Board Meeting

The Board of Directors of Vivimed Labs Limited has approved the unaudited financial results for the quarter and half-year ended September 30, 2024, along with the results for the quarter ended June 30, 2024. Additionally, Mr. Phanindernath Petasonti has been appointed as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company, effective January 10, 2025. The board's decisions imply a strategic focus on enhancing financial management and transparency moving forward.